Datamonitor’s OTC Pharmaceuticals: Global Industry Almanac: Global Industry Almanac is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Covers the Global, European and Asia-Pacific markets as well as individual chapters on Australia, Belgium, Brazil, Canada, China, Czech Republic, Denmark, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Norway, Poland, Russia, Singapore, South Africa, South Korea, Spain, Sweden, United Kingdom and United States.
* Includes a five-year forecast of the industry
Highlights
The global OTC pharmaceuticals market grew by 3.9% in 2009 to reach a value of $110.7 billion.
In 2014, the global OTC pharmaceuticals market is forecast to have a value of $131.6 billion, an increase of 18.9% since 2009.
Cough and cold preparations is the largest segment of the global OTC pharmaceuticals market, accounting for 17.6% of the market’s total value.
Europe accounts for 38% of the global OTC pharmaceuticals market value.
Johnson & Johnson is the leading player in the global OTC pharmaceuticals market, generating a 12.8% share of the market’s value.
The global over-the-counter (OTC) pharmaceutical market is highly fragmented, with the top three players holding 23% of the total market by value.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition
The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).
EXECUTIVE SUMMARY 2
INTRODUCTION 52
What is this report about? 52
Who is the target reader? 52
Market definition 52
GLOBAL OTC PHARMACEUTICALS 53
MARKET OVERVIEW 53
MARKET VALUE 54
MARKET SEGMENTATION I 55
MARKET SEGMENTATION II 56
MARKET SHARE 57
FIVE FORCES ANALYSIS 58
LEADING COMPANIES 66
MARKET DISTRIBUTION 85
MARKET FORECASTS 86
OTC PHARMACEUTICALS IN ASIAPACIFIC 88
MARKET OVERVIEW 88
MARKET VALUE 89
MARKET SEGMENTATION I 90
MARKET SEGMENTATION II 91
MARKET SHARE 92
FIVE FORCES ANALYSIS 93
LEADING COMPANIES 101
MARKET DISTRIBUTION 118
MARKET FORECASTS 119
OTC PHARMACEUTICALS IN EUROPE 121
MARKET OVERVIEW 121
MARKET VALUE 122
MARKET SEGMENTATION I 123
MARKET SEGMENTATION II 124
MARKET SHARE 125
FIVE FORCES ANALYSIS 126
LEADING COMPANIES 134
MARKET DISTRIBUTION 152
MARKET FORECASTS 153
OTC PHARMACEUTICALS IN AUSTRALIA 155
MARKET OVERVIEW 155
MARKET VALUE 156
MARKET SEGMENTATION I 157
MARKET SEGMENTATION II 158
MARKET SHARE 159
FIVE FORCES ANALYSIS 160
LEADING COMPANIES 167
MARKET DISTRIBUTION 183
MARKET FORECASTS 184
MACROECONOMIC INDICATORS 186
OTC PHARMACEUTICALS IN BELGIUM 188
MARKET OVERVIEW 188
MARKET VALUE 189
MARKET SEGMENTATION I 190
MARKET SEGMENTATION II 191
MARKET SHARE 192
FIVE FORCES ANALYSIS 193
LEADING COMPANIES 201
MARKET DISTRIBUTION 217
MARKET FORECASTS 218
MACROECONOMIC INDICATORS 220
OTC PHARMACEUTICALS IN BRAZIL 222
MARKET OVERVIEW 222
MARKET VALUE 223
MARKET SEGMENTATION I 224
MARKET SEGMENTATION II 225
MARKET SHARE 226
FIVE FORCES ANALYSIS 227
LEADING COMPANIES 235
MARKET DISTRIBUTION 251
MARKET FORECASTS 252
MACROECONOMIC INDICATORS 254
OTC PHARMACEUTICALS IN CANADA 256
MARKET OVERVIEW 256
MARKET VALUE 257
MARKET SEGMENTATION I 258
MARKET SEGMENTATION II 259
MARKET SHARE 260
FIVE FORCES ANALYSIS 261
LEADING COMPANIES 269
MARKET DISTRIBUTION 283
MARKET FORECASTS 284
MACROECONOMIC INDICATORS 286
OTC PHARMACEUTICALS IN CHINA 288
MARKET OVERVIEW 288
MARKET VALUE 289
MARKET SEGMENTATION I 290
MARKET SEGMENTATION II 291
MARKET SHARE 292
FIVE FORCES ANALYSIS 293
LEADING COMPANIES 301
MARKET DISTRIBUTION 313
MARKET FORECASTS 314
MACROECONOMIC INDICATORS 316
OTC PHARMACEUTICALS IN THE CZECH REPUBLIC 318
MARKET OVERVIEW 318
MARKET VALUE 319
MARKET SEGMENTATION I 320
MARKET SEGMENTATION II 321
MARKET SHARE 322
FIVE FORCES ANALYSIS 323
LEADING COMPANIES 331
MARKET DISTRIBUTION 345
MARKET FORECASTS 346
MACROECONOMIC INDICATORS 348
OTC PHARMACEUTICALS IN DENMARK 350
MARKET OVERVIEW 350
MARKET VALUE 351
MARKET SEGMENTATION I 352
MARKET SEGMENTATION II 353
MARKET SHARE 354
FIVE FORCES ANALYSIS 355
LEADING COMPANIES 363
MARKET DISTRIBUTION 380
MARKET FORECASTS 381
MACROECONOMIC INDICATORS 383
OTC PHARMACEUTICALS IN FRANCE 385
MARKET OVERVIEW 385
MARKET VALUE 386
MARKET SEGMENTATION I 387
MARKET SEGMENTATION II 388
MARKET SHARE 389
FIVE FORCES ANALYSIS 390
LEADING COMPANIES 398
MARKET DISTRIBUTION 413
MARKET FORECASTS 414
MACROECONOMIC INDICATORS 416
OTC PHARMACEUTICALS IN GERMANY 418
MARKET OVERVIEW 418
MARKET VALUE 419
MARKET SEGMENTATION I 420
MARKET SEGMENTATION II 421
MARKET SHARE 422
FIVE FORCES ANALYSIS 423
LEADING COMPANIES 430
MARKET DISTRIBUTION 448
MARKET FORECASTS 449
MACROECONOMIC INDICATORS 451
OTC PHARMACEUTICALS IN HUNGARY 453
MARKET OVERVIEW 453
MARKET VALUE 454
MARKET SEGMENTATION I 455
MARKET SEGMENTATION II 456
MARKET SHARE 457
FIVE FORCES ANALYSIS 458
LEADING COMPANIES 466
MARKET DISTRIBUTION 477
MARKET FORECASTS 478
MACROECONOMIC INDICATORS 480
OTC PHARMACEUTICALS IN INDIA 482
MARKET OVERVIEW 482
MARKET VALUE 483
MARKET SEGMENTATION I 484
MARKET SEGMENTATION II 485
MARKET SHARE 486
FIVE FORCES ANALYSIS 487
LEADING COMPANIES 495
MARKET DISTRIBUTION 513
MARKET FORECASTS 514
MACROECONOMIC INDICATORS 516
OTC PHARMACEUTICALS IN ITALY 518
MARKET OVERVIEW 518
MARKET VALUE 519
MARKET SEGMENTATION I 520
MARKET SEGMENTATION II 521
MARKET SHARE 522
FIVE FORCES ANALYSIS 523
LEADING COMPANIES 531
MARKET DISTRIBUTION 550
MARKET FORECASTS 551
MACROECONOMIC INDICATORS 553
OTC PHARMACEUTICALS IN JAPAN 555
MARKET OVERVIEW 555
MARKET VALUE 556
MARKET SEGMENTATION I 557
MARKET SEGMENTATION II 558
MARKET SHARE 559
FIVE FORCES ANALYSIS 560
LEADING COMPANIES 567
MARKET DISTRIBUTION 580
MARKET FORECASTS 581
MACROECONOMIC INDICATORS 583
OTC PHARMACEUTICALS IN MEXICO 585
MARKET OVERVIEW 585
MARKET VALUE 586
MARKET SEGMENTATION I 587
MARKET SEGMENTATION II 588
MARKET SHARE 589
FIVE FORCES ANALYSIS 590
LEADING COMPANIES 598
MARKET DISTRIBUTION 616
MARKET FORECASTS 617
MACROECONOMIC INDICATORS 619
OTC PHARMACEUTICALS IN THE NETHERLANDS 621
MARKET OVERVIEW 621
MARKET VALUE 622
MARKET SEGMENTATION I 623
MARKET SEGMENTATION II 624
MARKET SHARE 625
FIVE FORCES ANALYSIS 626
LEADING COMPANIES 634
MARKET DISTRIBUTION 652
MARKET FORECASTS 653
MACROECONOMIC INDICATORS 655
OTC PHARMACEUTICALS IN NORWAY 657
MARKET OVERVIEW 657
MARKET VALUE 658
MARKET SEGMENTATION I 659
MARKET SEGMENTATION II 660
MARKET SHARE 661
FIVE FORCES ANALYSIS 662
LEADING COMPANIES 670
MARKET DISTRIBUTION 687
MARKET FORECASTS 688
MACROECONOMIC INDICATORS 690
OTC PHARMACEUTICALS IN POLAND 692
MARKET OVERVIEW 692
MARKET VALUE 693
MARKET SEGMENTATION I 694
MARKET SEGMENTATION II 695
MARKET SHARE 696
FIVE FORCES ANALYSIS 697
LEADING COMPANIES 705
MARKET DISTRIBUTION 715
MARKET FORECASTS 716
MACROECONOMIC INDICATORS 718
OTC PHARMACEUTICALS IN RUSSIA 720
MARKET OVERVIEW 720
MARKET VALUE 721
MARKET SEGMENTATION I 722
MARKET SEGMENTATION II 723
MARKET SHARE 724
FIVE FORCES ANALYSIS 725
LEADING COMPANIES 733
MARKET DISTRIBUTION 749
MARKET FORECASTS 750
MACROECONOMIC INDICATORS 752
OTC PHARMACEUTICALS IN SINGAPORE 754
MARKET OVERVIEW 754
MARKET VALUE 755
MARKET SEGMENTATION I 756
MARKET SEGMENTATION II 757
MARKET SHARE 758
FIVE FORCES ANALYSIS 759
LEADING COMPANIES 767
MARKET DISTRIBUTION 784
MARKET FORECASTS 785
MACROECONOMIC INDICATORS 787
OTC PHARMACEUTICALS IN SOUTH AFRICA 789
MARKET OVERVIEW 789
MARKET VALUE 790
MARKET SEGMENTATION I 791
MARKET SHARE 792
FIVE FORCES ANALYSIS 793
LEADING COMPANIES 801
MARKET DISTRIBUTION 809
MARKET FORECASTS 810
MACROECONOMIC INDICATORS 812
OTC PHARMACEUTICALS IN SOUTH KOREA 814
MARKET OVERVIEW 814
MARKET VALUE 815
MARKET SEGMENTATION I 816
MARKET SEGMENTATION II 817
MARKET SHARE 818
FIVE FORCES ANALYSIS 819
LEADING COMPANIES 827
MARKET DISTRIBUTION 840
MARKET FORECASTS 841
MACROECONOMIC INDICATORS 843
OTC PHARMACEUTICALS IN SPAIN 845
MARKET OVERVIEW 845
MARKET VALUE 846
MARKET SEGMENTATION I 847
MARKET SEGMENTATION II 848
MARKET SHARE 849
FIVE FORCES ANALYSIS 850
LEADING COMPANIES 858
MARKET DISTRIBUTION 875
MARKET FORECASTS 876
MACROECONOMIC INDICATORS 878
OTC PHARMACEUTICALS IN SWEDEN 880
MARKET OVERVIEW 880
MARKET VALUE 881
MARKET SEGMENTATION I 882
MARKET SEGMENTATION II 883
MARKET SHARE 884
FIVE FORCES ANALYSIS 885
LEADING COMPANIES 893
MARKET DISTRIBUTION 910
MARKET FORECASTS 911
MACROECONOMIC INDICATORS 913
OTC PHARMACEUTICALS IN THE UNITED KINGDOM 915
MARKET OVERVIEW 915
MARKET VALUE 916
MARKET SEGMENTATION I 917
MARKET SEGMENTATION II 918
MARKET SHARE 919
FIVE FORCES ANALYSIS 920
LEADING COMPANIES 928
MARKET DISTRIBUTION 945
MARKET FORECASTS 946
MACROECONOMIC INDICATORS 948
OTC PHARMACEUTICALS IN THE UNITED STATES 950
MARKET OVERVIEW 950
MARKET VALUE 951
MARKET SEGMENTATION I 952
MARKET SEGMENTATION II 953
MARKET SHARE 954
FIVE FORCES ANALYSIS 955
LEADING COMPANIES 963
MARKET DISTRIBUTION 979
MARKET FORECASTS 980
MACROECONOMIC INDICATORS 982
APPENDIX 984
Data Research Methodology 984
About Datamonitor 985
Disclaimer 985
Other selected research from the 'OTC' category:
Hormonal Contraceptives Market Forecast
Personal Hygiene/ Personal Care: Brazil Industry Guide